Mills GB - Search Results

1

Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.

Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Tabe Y, et al. Among authors: mills gb. Cancer Res. 2007 Jan 15;67(2):684-94. doi: 10.1158/0008-5472.CAN-06-3166. Cancer Res. 2007. PMID: 17234779

2

Lysophospholipids activate ovarian and breast cancer cells.

Xu Y, Fang XJ, Casey G, Mills GB. Xu Y, et al. Among authors: mills gb. Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):933-40. doi: 10.1042/bj3090933. Biochem J. 1995. PMID: 7639713 Free PMC article.

3

Effect of lysophospholipids on signaling in the human Jurkat T cell line.

Xu Y, Casey G, Mills GB. Xu Y, et al. Among authors: mills gb. J Cell Physiol. 1995 Jun;163(3):441-50. doi: 10.1002/jcp.1041630303. J Cell Physiol. 1995. PMID: 7775587

4

Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.

Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB, Steck PA. Davies MA, et al. Among authors: mills gb. Cancer Res. 1998 Dec 1;58(23):5285-90. Cancer Res. 1998. PMID: 9850049

5

The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.

Xu F, Yu Y, Le XF, Boyer C, Mills GB, Bast RC Jr. Xu F, et al. Among authors: mills gb. Clin Cancer Res. 1999 Nov;5(11):3653-60. Clin Cancer Res. 1999. PMID: 10589783

6

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.

Fang X, Yu S, Eder A, Mao M, Bast RC Jr, Boyd D, Mills GB. Fang X, et al. Among authors: mills gb. Oncogene. 1999 Nov 18;18(48):6635-40. doi: 10.1038/sj.onc.1203076. Oncogene. 1999. PMID: 10597268

7

Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.

Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MA, Lu Y, Fang X, Tsutsui S, Siddik ZH, Bast RC, Mills GB. Furui T, et al. Among authors: mills gb. Clin Cancer Res. 1999 Dec;5(12):4308-18. Clin Cancer Res. 1999. PMID: 10632375

8

Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms.

Le XF, McWatters A, Wiener J, Wu JY, Mills GB, Bast RC Jr. Le XF, et al. Among authors: mills gb. Clin Cancer Res. 2000 Jan;6(1):260-70. Clin Cancer Res. 2000. PMID: 10656457

9

Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.

Ramondetta L, Mills GB, Burke TW, Wolf JK. Ramondetta L, et al. Among authors: mills gb. Clin Cancer Res. 2000 Jan;6(1):278-84. Clin Cancer Res. 2000. PMID: 10656459

10

Differential signaling by an anti-p185(HER2) antibody and heregulin.

Le XF, Vadlamudi R, McWatters A, Bae DS, Mills GB, Kumar R, Bast RC Jr. Le XF, et al. Among authors: mills gb. Cancer Res. 2000 Jul 1;60(13):3522-31. Cancer Res. 2000. PMID: 10910064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,153 results

Search Page

Filters